Research Center for Clinical Neuroimmunology and Neuroscience

Advancing Science, Enhancing Lives

RC2NB is a leading destination for cutting-edge research and clinical innovation. As an academic-industry initiative, we are committed to advancing Neuroimmunology and Neuroscience, specifically focusing on understanding and treating Multiple Sclerosis and other neuroimmune diseases.

ABOUT US
+118

Peer-Reviewed Publications in 2024

+100

Active Research Projects

+20

Membership in International Commites and Boards

+20M

CHF in Competitive Research Funding

+700

MS Patients enrolled in Clinical studies

+10

Nationalities &
Diverse Professional Backgrounds

+40

PhD/Master students

+30

Top Awards and Accreditations from International Organizations

343K

biosamples

FOUR WORKSTREAMS

- ONE VISION -

WORKSTREAM 1:
DIGITAL FUTURE

This workstream presents you "Dreams": Digital biomarkers generated with a smartphone app in combination with a smartwatch enable continuous comprehensive monitoring of disease evolution in people with MS.

MORE

WORKSTREAM 2:
INNOVATIVE IMAGING AND ANALYSIS OF BODY FLUIDS

This workstream provides an understanding of multiple sclerosis (MS) physiopathology, the identification of biomarkers of MS progression and therapy response and the development of new computational models of MS disease impact and evolution.
MORE

WORKSTREAM 3:
RECORDING AND UNDERSTANDING
THE DYSREGULATED IMMUNE SYSTEM

This workstream provides a solid understanding of the immune system regulation and dysregulation is central for diagnosis, prognostic assessment, and treatment of neuroimmunological diseases.
MORE

WORKSTREAM 4:
PRAGMATIC TRIALS AND REAL-WORLD EVIDENCE

This workstream provides the framework to systematically evaluate patient-relevant benefits resulting from therapeutic and diagnostic innovations developed at RC2NB.

MORE

RC2NB in a nutshell

Advancing science, enhancing lives!

News & Events

Upcoming Events and latest news

We are looking for / Wir suchen eine/n Assistent/in der Geschäftsleitung 50-60%

Patient Stories That Inspire

RC2NB Annual Report 2024 – Driving Impact Through Innovation 

The Clinnova Website is LIVE!

OUR MISSION

RC2NB’s mission is to strengthen internationally recognized expertise and innovative research projects and complement them with the development and validation of digital biomarkers and innovative methods of information processing and artificial intelligence.

OUR VISION

Improving the life of people with MS and other neurological diseases through the development and integration of innovative tools that comprehensively characterize the disease process, facilitate the development and implementation of better treatments and enable personalized disease management.

Management Group

Members of the management group representing the four workstreams of RC2NB and meeting monthly to facilitate continuous exchange on and coordination of ongoing and planned research projects.

Partnering Institutions and Research Support

Our work is only possible thanks to the broad support of our institutional donors. We consider ourselves very fortunate to have received very generous donations and to be able to build on our long-standing partnerships with our supporters.
© RC2NB 2025
databasegraduation-hatuserssmartphoneheart-pulseearthcrossmenuchevron-downframe-expand